Roeland Vanhauwaert

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Low Density Lipoprotein

Myasthenia Gravis

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Julien Oury, Begona Gamallo-Lana, Leah Santana, Christophe Steyaert, Dana L E Vergoossen, Adam C Mar, Bernhardt Vankerckhoven, Karen Silence, Roeland Vanhauwaert, Maartje G Huijbers, Steven J Burden
Agonist antibody to MuSK protects mice from MuSK myasthenia gravis. Proceedings of the National Academy of Sciences of the United States of America 121 (39) (2024)
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven, Christophe Steyaert, Stine Marie Jensen, Dana L E Vergoossen, Christa Kneip, Leah Santana, Jamie L Lim, Jaap J Plomp, Roy Augustinus, Shohei Koide, Christophe Blanchetot, Peter Ulrichts, Maartje G Huijbers, Karen Silence, Steven J Burden
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome. Science translational medicine 16 (765) (2024)